Kevin J Stefanski

Title: Kevin J Stefanski – Innovator in Bioavailable Compositions

Introduction

Kevin J Stefanski, an inventive mind based in Burlington, NJ, has made significant contributions to the field of pharmaceutical sciences. He holds one patent that embodies his commitment to enhancing bioavailability in drug formulations, demonstrating a blend of innovation and practical application in the industry.

Latest Patents

Stefanski's notable patent is titled "Bioavailable Compositions of Amorphous Piperidinyl Compounds." This invention focuses on solid amorphous dispersions comprising a specific compound, identified as Compound I, along with various polymers. The uniqueness of this invention lies in its provision of amorphous solid dispersions that are not only remarkably stable in suspension and solid state but also have extended longevity for tableting purposes, marking a significant advancement in the formulation of pharmaceutical compounds.

Career Highlights

Kevin J Stefanski is affiliated with Bristol-Myers Squibb Company, a leader in the pharmaceutical industry. His career at this esteemed organization has allowed him to explore innovative solutions to challenging problems, particularly in the realm of drug delivery and efficacy.

Collaborations

Throughout his career, Stefanski has collaborated with notable professionals, including Rodney D Vickery and Ching-Chiang Su. These collaborations exemplify the collaborative spirit of innovation, where shared knowledge leads to breakthroughs in the development of new pharmaceutical compositions.

Conclusion

Kevin J Stefanski continues to push the boundaries of pharmaceutical sciences with his inventive spirit and dedication to enhancing drug formulations. His contributions not only reflect his expertise as an inventor but also his commitment to improving patient outcomes through innovative solutions in the industry.